Shares in the Auckland-based drugmaker, AFT Pharmaceutical, have had a strong debut on the New Zealand stock exchange, trading at a 14 percent premium to their issue price.
Shares in the Auckland-based drugmaker, AFT Pharmaceutical, have had a strong debut on the New Zealand stock exchange, trading at a 14 percent premium to their issue price.